The Society for Neuro-Oncology and the European Association of Neuro-Oncology are pleased to announce the second SNO-EANO webinar which will address the scientific highlights of the SNO and EANO conferences held in September and November of last year respectively.
Webinar on "Best of EANO & SNO 2023"
February 20, 2024 from 18:30-19:30hrs CET (12:30pm-1:30pm ET)
Chair: A.Golebiewska, Luxembourg, LU and Shawn Hervey-Jumper, San Francisco, USA
- CTNI-73 - Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas, Priscilla K. Brastianos, Massachusetts, USA
- Olfactory sensory experience regulates gliomagenesis via neuronal IGF1, Chong Liu, Hangzhou, P.R. China
- Spatio-temporal remodeling of tumor architecture under therapy, Dieter Henrik Heiland, Freiburg, Germany
- BIOM-55 - Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses, William C. Chen, San Francisco, USA
- EXTH 36- Combining ONC201 and paxalisib for the treatment of diffuse midline glioma (DMG); the preclinical results underpinning the international Phase II clinical trial (NCT05009992), Evangeline R. Jackson, Newcastle, Australia
- Review of the impact of molecular classification in the management of pediatric brain tumors, Richard Gilbertson, Cambridge, UK
EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis and treatment of tumours of the central nervous system (CNS). EANO is dedicated to promote advances in Neuro-Oncology through innovative research and concerted education and training. It enhances collaboration between all relevant disciplines - Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology, and Radiation Oncology as well as Nursing - and aims at bridging science, knowledge and practice gaps in the management of CNS malignancies.
Today, EANO has over 700 members from more than 70 countries. EANO stimulates (inter)national cooperation together with our major partner societies, the Society of Neuro-Oncology in the US (SNO) and the Asian Society of Neuro-Oncology (ASNO); together, EANO, SNO and ASNO are charter societies of the World Federation of Neuro-Oncology Societies (WFNOS).
EANO provides multiple services to its members. We organise scientific and educational webinars and meetings with 'state of the art' lectures covering the broad spectrum of all disciplines in Neuro-Oncology, including our flagship annual EANO Meeting and the quadrennial WFNOS Meeting.
Further, EANO offers exclusively to its members free access to Neuro Oncology, Neuro Oncology Practice and the Neuro Oncology Advances Journals.
EANO considers the preparation of multidisciplinary guidelines as a prime task to support the development of high quality care for brain tumour patients across Europe. The EANO Youngster Initiative is a highly active platform for exchange, networking and career support for young clinicians and scientists. We also offer high level post-graduate education through the EANO School of Neuro-Oncology launched in 2022 and strongly support increasing diversity in the Neuro-Oncology community.
EANO President (2022-2024)